scholarly article | Q13442814 |
P356 | DOI | 10.1046/J.1463-1326.2002.00179.X |
P698 | PubMed publication ID | 11940106 |
P2093 | author name string | Jakobsen P | |
Andersen B | |||
Madsen P | |||
Westergaard N | |||
Lundbeck JM | |||
Varming A | |||
P2860 | cites work | Pathogenesis of NIDDM. A balanced overview | Q43832606 |
Glucose-6-phosphatase mRNA and activity are increased to the same extent in kidney and liver of diabetic rats. | Q51580925 | ||
Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase. | Q52524271 | ||
Vanadate: A potent inhibitor of multifunctional glucose-6-phosphatase | Q53804798 | ||
Sequence of a putative glucose 6-phosphate translocase, mutated in glycogen storage disease type Ib | Q24320082 | ||
Mechanisms of blood glucose homeostasis | Q28329652 | ||
Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase | Q28569826 | ||
Effect of acute diabetes on rat hepatic glucose-6-phosphatase activity and its messenger RNA level | Q30465921 | ||
Alterations of carbohydrate and lipid intermediary metabolism during inhibition of glucose-6-phosphatase in rats | Q33179366 | ||
Regulation of glucose production by the liver | Q33711817 | ||
The structural basis of insulin and insulin-like growth factor-I receptor binding and negative co-operativity, and its relevance to mitogenic versus metabolic signalling. | Q34315974 | ||
The molecular basis of the type 1 glycogen storage diseases | Q35701957 | ||
Role of liver in pathophysiology of NIDDM | Q35981585 | ||
Isolation of a cDNA for the catalytic subunit of rat liver glucose-6-phosphatase: regulation of gene expression in FAO hepatoma cells by insulin, dexamethasone and cAMP. | Q36751840 | ||
Regulation of rat liver glucose-6-phosphatase gene expression in different nutritional and hormonal states: gene structure and 5'-flanking sequence | Q36826589 | ||
Chlorogenic acid and synthetic chlorogenic acid derivatives: novel inhibitors of hepatic glucose-6-phosphate translocase | Q36843170 | ||
The molecular basis of the hepatic microsomal glucose-6-phosphatase system | Q37173118 | ||
Autoregulation of hepatic glucose production | Q41737250 | ||
Permeability of rat liver microsomal membrane to glucose 6-phosphate | Q41884105 | ||
Specific features of glycogen metabolism in the liver | Q42051685 | ||
Peroxyvanadium compounds inhibit glucose-6-phosphatase activity and glucagon-stimulated hepatic glucose output in the rat in vivo. | Q42472345 | ||
P433 | issue | 2 | |
P921 | main subject | glucose | Q37525 |
glycobiology | Q899224 | ||
P304 | page(s) | 96-105 | |
P577 | publication date | 2002-03-01 | |
P1433 | published in | Diabetes, Obesity and Metabolism | Q5270109 |
P1476 | title | Identification of two novel and potent competitive inhibitors of the glucose-6-phosphatase catalytic protein | |
P478 | volume | 4 |
Q78419821 | Current literature in diabetes |
Q28118176 | Enzymatic characterization of the pancreatic islet-specific glucose-6-phosphatase-related protein (IGRP) |
Q38880714 | Genetic and molecular analyses reveal G6PC as a key element connecting glucose metabolism and cell cycle control in ovarian cancer |